HKSE - Delayed Quote HKD
OCUMENSION-B (1477.HK)
5.520
-0.010
(-0.18%)
At close: April 25 at 4:08:21 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-174,691
-177,927
-200,657
-196,849
-212,574
Investing Cash Flow
523,752
-259,784
229,146
-1,345,290
629,696
Financing Cash Flow
-19,015
108,660
-9,222
668,852
1,527,360
End Cash Position
867,090
842,839
1,170,049
1,125,221
2,034,319
Capital Expenditure
-291,927
-361,867
-310,003
-664,809
-304,609
Issuance of Capital Stock
7,879
5,595
12,720
684,731
1,611,139
Issuance of Debt
150,000
120,000
--
--
--
Repayment of Debt
-150,000
-1,810
--
--
--
Repurchase of Capital Stock
-10,754
-1,462
-11,002
-1,388
--
Free Cash Flow
-466,618
-539,794
-510,660
-861,658
-517,183
12/31/2020 - 7/10/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6821.HK Asymchem Laboratories (Tianjin) Co., Ltd.
50.650
-3.25%
2171.HK CARsgen Therapeutics Holdings Limited
15.400
-1.91%
1541.HK IMMUNEONCO-B
7.080
-0.28%
6622.HK Zhaoke Ophthalmology Limited
1.740
+6.10%
2509.HK Qyuns Therapeutics Co., Ltd.
10.960
+3.59%
1548.HK GENSCRIPT BIO
11.060
-1.25%
2157.HK Lepu Biopharma Co., Ltd.
4.350
-3.97%
2137.HK Brii Biosciences Limited
2.000
+8.11%
9995.HK RemeGen Co., Ltd.
43.450
+5.08%
2696.HK Shanghai Henlius Biotech, Inc.
37.850
-2.82%